cerrar
Tagged with Oncology

Christian Probst – General Manager, GSK Norway
Christian Probst gives an overview of GSK Norway’s broad portfolio, market access hurdles, and the importance of bringing clinical trials back to…

Novartis Oncology US: Leaning into Change
With a series of reorganization initiatives, new leaders at the helm and exciting acquisitions, Novartis Oncology has undergone a significant business…

Novartis Oncology President: “If We Offer Pay-For-Performance,…
During the FT Global Pharmaceutical and Biotechnology Conference earlier this month, three industry leaders spoke about innovative reimbursement…

Eisai Targeting Global Leadership in Neurology & Oncology…
Founded by Toyoji Naito in December 1941, in just under 80 years, Eisai has become a leading global biopharma player, with pharmaceutical revenues of…

Dan Schneider – President & CEO, Photocure
Dan Schneider discusses the continuing Norwegian identity of Photocure, despite its increasingly global footprint, the company's strategy, and his…

Jan Børge Jakobsen – MD, Bayer Norway
Jan Børge Jakobsen, managing director of Bayer Norway, shares how he came to lead Bayer’s Norwegian affiliate after 30 years within the Norwegian…

Philipp Maerz – Head of Northern Cluster & GM Norway,…
Philipp Maerz, the recently appointed head of Merck’s Nordic and Baltic operations and GM for Norway, outlines the challenges of taking on a new…

Axel Steiger – CEO, Bayer Switzerland
Axel Steiger, CEO and CFO for Bayer Switzerland, outlines the importance of the Swiss operations as one of the key global hubs for Bayer, his…

Jon Amund Kyte – Head, Department of Experimental Cancer…
[caption id="attachment_92156" align="alignleft" width="227"] Photo: Sofia Linden / Oslo Cancer Cluster[/caption] Oncologist Jon Amund Kyte shares…

Ole Alexander Opdalshei – Assistant Secretary General,…
Ole Alexander Opdalshei introduces the role of the Norwegian Cancer Society within Norwegian cancer research, care services and information…

Thomas Willemsen – SVP APAC, Takeda
In an exclusive and wide-ranging interview, Takeda APAC SVP Thomas Willemsen outlines his strategy for bringing the company’s specialty pharma…

Michael G. Kauffman – Founder & CEO, Karyopharm…
Karyopharm Therapeutics’ Dr Michael G. Kauffman outlines the genesis of the company he co-founded with his wife, the approval journey of key product…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here